Literature DB >> 8078498

Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.

V Asghari1, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis, H H Van Tol.   

Abstract

Recent molecular characterization of the human D4 gene has revealed the existence of various polymorphic forms of this receptor. These variations are found in the putative third cytoplasmic loop region and encode a variable number of repeats of 16 amino acids in length. In the present study we have compared the pharmacological binding profiles of seven different polymorphic variants of the human D4 receptor, the rat D4 receptor, and two different human D4 receptor mutants that were deleted in the repeat sequence. For this purpose we cloned the rat D4 receptor gene and compared its gene structure and its pharmacological binding profile with those of the D4.4 and D4.7 genes. The rat and human D4 genes display a high degree of sequence similarity, especially in the coding regions. An Alu repeat sequence was identified in the first intron of the human D4 gene but is not present in the rat D4 gene. Furthermore, using the polymerase chain reaction we cloned 3-, 5-, 6-, and 9-fold repeat sequences. These cloned repeat sequences were used for the reconstruction of full length cDNAs encoding D4.3, D4.5, D4.6, and D4.9, respectively. These novel forms of the human D4 receptor, as well as the previously cloned D4.2, D4.4, and D4.7 forms, were transiently expressed in COS-7 cells. All of the different forms of the human and rat D4 receptors and repeat deletion mutants displayed similar binding profiles for all ligands tested, although small differences were observed. The affinity for dopamine could be decreased by guanosine-5'-(beta, gamma-imido)triphosphate with the different forms of the D4 receptor, including the two receptor mutants that were deleted in the repeat sequence. These data suggest that the polymorphic repeat sequence has little influence on D4 binding profiles and might not be essential for G protein interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078498

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  33 in total

Review 1.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

2.  Differential Susceptibility: The Genetic Moderation of Peer Pressure on Alcohol Use.

Authors:  Amanda M Griffin; H Harrington Cleveland; Gabriel L Schlomer; David J Vandenbergh; Mark E Feinberg
Journal:  J Youth Adolesc       Date:  2015-08-26

3.  Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Authors:  Xiaomeng Xu; Uraina S Clark; Sean P David; Richard C Mulligan; Valerie S Knopik; John McGeary; James MacKillop; Jeanne McCaffery; Raymond S Niaura; Lawrence H Sweet
Journal:  Nicotine Tob Res       Date:  2014-03-22       Impact factor: 4.244

4.  D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects.

Authors:  J Gelernter; H Kranzler; E Coccaro; L Siever; A New; C L Mulgrew
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

Review 5.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

6.  A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder.

Authors:  L Cinnamon Bidwell; Erik G Willcutt; Matthew B McQueen; John C DeFries; Richard K Olson; Shelley D Smith; Bruce F Pennington
Journal:  Behav Genet       Date:  2011-01-05       Impact factor: 2.805

7.  Interaction between prenatal stress and dopamine D4 receptor genotype in predicting aggression and cortisol levels in young adults.

Authors:  Arlette F Buchmann; Katrin Zohsel; Dorothea Blomeyer; Erika Hohm; Sarah Hohmann; Christine Jennen-Steinmetz; Jens Treutlein; Katja Becker; Tobias Banaschewski; Martin H Schmidt; Günter Esser; Daniel Brandeis; Luise Poustka; Ulrich S Zimmermann; Manfred Laucht
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

8.  A differential susceptibility analysis reveals the "who and how" about adolescents' responses to preventive interventions: tests of first- and second-generation Gene × Intervention hypotheses.

Authors:  Gene H Brody; Tianyi Yu; Steven R H Beach
Journal:  Dev Psychopathol       Date:  2015-02

9.  Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.

Authors:  A M Leventhal; S P David; M Brightman; D Strong; J E McGeary; R A Brown; E E Lloyd-Richardson; M Munafò; G R Uhl; R Niaura
Journal:  Pharmacogenomics J       Date:  2010-07-27       Impact factor: 3.550

10.  Assortative human pair-bonding for partner ancestry and allelic variation of the dopamine receptor D4 (DRD4) gene.

Authors:  Dan T A Eisenberg; Coren L Apicella; Benjamin C Campbell; Anna Dreber; Justin R Garcia; J Koji Lum
Journal:  Soc Cogn Affect Neurosci       Date:  2009-08-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.